companydata.dkcompanydata.dk

GSK 2023 ApS: Financial statements 2022

CVR: 43456415

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

GSK 2023 ApS (CVR 43456415) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -570,374 and a net result of DKK 23,036,259 compared with DKK 10,078,286 the year before. Equity in the 2022 report amounted to DKK 91,200,560. The solvency ratio was 95.3%. The company had 1 employee in the financial year.

Gross Profit
DKK -570,374
Profit/Loss
DKK 23,036,259
Equity
DKK 91,200,560
Total Assets
DKK 95,704,680
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--570K23M91.2M1
2021--341K10.1M85.6M1
2020--316K3.5M75.6M1
2019--288K7.8M72.3M1
2018--267K-1.8M64.6M0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on GSK 2023 ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

GSK 2023 ApS: The 2021 annual report is outMay 5, 2022

GSK 2023 ApS has published its annual report for 2021. Gross profit came to DKK -340,841, and the net result was DKK 10,078,286.

About GSK 2023 ApS

GSK 2023 ApS is a Danish company of the type Anpartsselskab based in Sæby, founded in 1972. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named B6 HOLDING A/S and B 6 AF 1972 A/S. The management consists of Brian Stenbro. The board consists of Kurt Valdemar Stenbro (chair), Brian Stenbro and Malene Stenbro. The company is owned by M.A.S.T. Holding ApS, BriSt Holding 2023 ApS and KVS Holding, Sæby ApS. The company has 2 employees (2023). In 2025, the company reported a gross profit of DKK -30,332 and a net result of DKK -5,937 compared with DKK 372,677 the year before. Equity in the 2025 report amounted to DKK 4,181,703.

Source: annual report 2025, Danish Business Authority